1H-indole-3-carboxylic acid, (6R,9AS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel-, methanesulfonate, hydrate (1:1:1),
1H-indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2-alpha,6-alpha,8-alpha,9a-beta)-,
1H-indole-3-carboxylic acid-trans-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester methanesulfonate,
Anzemet,
dolasetron,
dolasetron mesilate monohydrate,
dolasetron mesylate,
dolasetron mesylate monohydrate,
indole-3-carboxylic acid, ester with (8R)-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one,
MDL 73,147EF,
MDL 73147EF,
MDL-73147EF,
octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl 1H-indole-3-carboxylate,
DOLASETRON MESYLATE,
Dalasetron Mesylate Hydrate,
878143-33-0,
Dalasetron (Mesylate hydrate),
Anzemet hydrate,
Dolasetron mesylate hydrate,
Dolasetron mesilate,
115956-13-3,
Dolasetron (Mesylate hydrate),
Dolasetron methanesulfonate hydrate,
DOLASETRON MESYLATE MONOHYDRATE,
Anzemet,
MDL-73147EF,
NCGC00181048-01,
Anemet,
SCHEMBL1237588,
CHEMBL2368924,
HY-B0750B,
QTFFGPOXNNGTGZ-LIFGOUTFSA-N,
HMS3714B12,
C19H20N2O3.CH4O3S.H2O,
AKOS030526960,
API0002473,
CCG-220885,
CCG-222446,
CS-3746,
AS-13228,
H668,
956D133,
Dolasetron mesylate hydrate, >=98% (HPLC), powder,
(2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate monomethanesulfonate,
Dolasetron mesylate [USAN],
UNII-71YF100S3H,
Dolasetron mesylate [USAN:USP],
MDL 73147EF,
C19H20N2O3.CH4O3S,
CID6918119,
C19-H20-N2-O3.C-H4-O3-S,
Indole-3-carboxylic acid, ester with (8R)-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one, monomethanesulfonate,